MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
Tickers BIIB ESALY LLY PRTA
Tags ESALY LLY PRTA
From Motley Fool
Why Acumen Pharmaceuticals Stock Is Soaring Today
Tickers ABOS BIIB ESALY
Tags Trading Ideas ESALY why it's moving
From Benzinga
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
Tickers BIIB ESALY LLY SAVA
Tags ESALY NASDAQ:BIIB,NYSE:LLY,NASDAQ:SAVA,OTCMKTS:ESALY Today's Market
From InvestorPlace
Why Is Biogen (BIIB) Stock Up 40% Today?
Tickers BIIB ESALY
Tags ESALY BIIB Today's Market
From InvestorPlace
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
Tickers AAPL AMZN BIIB BP
Tags Media Health Care Benzinga
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
Tickers BIIB ESALY
Tags BIIB Movers Market News
From Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Tickers BIIB ESALY SAVA
Tags Movers Market News BIIB
From Benzinga
Why Biogen Stock Is Up 40% Today
Tickers BIIB ESALY
Tags Market News Movers Benzinga
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
Tickers BIIB ESALY LLY RHHBY
Tags ESALY Benzinga lecanemab
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
Tickers AGCO BB BIIB CTAS
Tags Eurozone BB Markets
From Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Tickers BIIB ESALY
Tags JP:NIK BIIB ESALY
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags News General BIIB
From Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
Tickers ESALF ESALY MRK
Tags Market News Health Care News
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Tickers ESALF ESALY LLY RHHBF
Tags RHHBY Biotech Benzinga
From Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
Tickers BIIB ESALY
Tags Recent Press Releases Market News ESALY
From Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags KTRA ALNY Benzinga
From Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
Tickers ESALF ESALY MRK
Tags Biotech ESALF Benzinga
From Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
Tickers AZN ESALY MRK SGEN
Tags MRK ESALY SGEN
From Motley Fool
Is This Biotech Stock a Bad News Buy?
Tickers BIIB ESALY
Tags Recent Press Releases Market News ESALY
From Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Tickers AMTI BIIB ESALF ESALY
Tags Health Care EVOTF KZIA
From Benzinga
2 Safe Stocks to Buy in a Bear Market
Tickers AZN ESALY ISRG MDT
Tags AZN Recent Press Releases ISRG
From Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags Penny Stocks AGEN BIIB
From Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Briefs ESALY Biotech
From Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
Tickers BIIB ESALY SAGE
Tags ESALY BIIB SAGE
From Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
Tickers ESALY LLY PFE SPX
Tags ESALY PFE SPX
From MarketWatch
Is This Biotech Stock Worth the Trouble?
Tickers BIIB ESALY LLY SAGE
Tags ESALY BIIB SAGE
From Motley Fool
What This Regulatory Approval Could Mean for Merck
Tickers ESALY MRK PFE
Tags PFE MRK ESALY
From Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
Tickers ABIO ESALY IBB IMMP
Tags Benzinga Biotech FDA
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Market News Health Care ESALY
From Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags ESALY MRK Briefs
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story